OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Psychopharmacology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness	68
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping	35
Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis	34
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital	33
History repeating: guidelines to address common problems in psychedelic science	32
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study	30
Comment on: History repeating: guidelines to address common problems in psychedelic science	30
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial	29
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study	24
Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit	22
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry	20
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study	20
The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes	19
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system	19
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”	18
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?	18
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?	18
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey	17
Reasons for admission to a general medical hospital for patients taking clozapine	14
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review	13
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia	13
Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors	12
Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, s	12
Risperidone-induced priapism: a case report and literature review	12
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand	11

Will psilocybin lose its magic in the clinical setting?	11
Risperidone-induced neuroleptic malignant syndrome: a case report	11
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review	11
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications	10
Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’	10
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies	9
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia	9